Insider trading · Q3 2026 · CIK 1689375

Entrada Therapeutics, Inc. (TRDA) insider trading.

Name: Entrada Therapeutics, Inc. insider transactions, Q3 2026
Creator: U.S. Securities and Exchange Commission

In Q3 2026, insiders at Entrada Therapeutics, Inc. reported 37 non-derivative transactions on 16 Forms 3, 4 and 5: 0 open-market purchases and 33 sales worth $10.3M.

Transactions: 37
Purchases (P): 0
Sales (S): 33
Net shares, P minus S: -1,442,908
Insiders: 12
Last filed: 2026-09-09

Insiders

Insider	Relationship	Transactions	Sales
MPM BioVentures 2018 LLC / MPM BIOVENTURES 2018, L.P. / MPM BioVentures 2018 GP LLC	TenPercentOwner	9	9
Parmar Kush	Director	5	5
ROCKLAGE SCOTT M / 5AM Opportunities I, L.P. / 5AM Partners V, LLC / 5AM Opportunities I (GP), LLC / 5AM Ventures V, L.P. / Schwab Andrew J.	TenPercentOwner	4	4
MPM BIOVENTURES 2018 (B), L.P. / MPM Asset Management Investors BV2014 LLC / MPM BioVentures 2014 (B), L.P. / GADICKE ANSBERT / MPM BioVentures 2014, L.P. / MPM ASSET MANAGEMENT INVESTORS BV2018 LLC / Foley Todd / MPM BioVentures 2014 GP LLC / MPM BioVentures 2014 LLC / EVNIN LUKE	TenPercentOwner	3	3
MPM BioVentures 2018 GP LLC / MPM BioVentures 2018 LLC / MPM BIOVENTURES 2018, L.P.	TenPercentOwner	3	3
MPM BioVentures 2014 GP LLC / EVNIN LUKE / MPM Asset Management Investors BV2014 LLC / MPM BioVentures 2014 (B), L.P. / MPM BioVentures 2014 LLC / GADICKE ANSBERT / Foley Todd / MPM BioVentures 2014, L.P. / MPM ASSET MANAGEMENT INVESTORS BV2018 LLC / MPM BIOVENTURES 2018 (B), L.P.	TenPercentOwner	3	3
MPM BioVentures 2014 (B), L.P. / Foley Todd / MPM BioVentures 2014 GP LLC / MPM ASSET MANAGEMENT INVESTORS BV2018 LLC / GADICKE ANSBERT / MPM Asset Management Investors BV2014 LLC / MPM BioVentures 2014 LLC / MPM BIOVENTURES 2018 (B), L.P. / EVNIN LUKE / MPM BioVentures 2014, L.P.	TenPercentOwner	3	3
Foley Todd / MPM BioVentures 2014 GP LLC / MPM BioVentures 2014 LLC / MPM BioVentures 2014 (B), L.P. / MPM Asset Management Investors BV2014 LLC / GADICKE ANSBERT / MPM BIOVENTURES 2018 (B), L.P. / MPM BioVentures 2014, L.P. / EVNIN LUKE / MPM ASSET MANAGEMENT INVESTORS BV2018 LLC	TenPercentOwner	3	3
Doshi Dipal	Director, Officer · CEO	1	0
Wentworth Kory James	Officer · Chief Financial Officer	1	0
Dowden Nathan J	Officer · President & COO	1	0
Sethuraman Natarajan	Officer · President, Research & Develop.	1	0

Transactions

37 non-derivative rows, newest transaction first. Shares and prices as filed.
Date	Insider	Code	Shares	Price	Owned after	Filing
2026-09-09	MPM BIOVENTURES 2018 (B), L.P. / MPM Asset Management Investors BV2014 LLC / MPM BioVentures 2014 (B), L.P. / GADICKE ANSBERT / MPM BioVentures 2014, L.P. / MPM ASSET MANAGEMENT INVESTORS BV2018 LLC / Foley Todd / MPM BioVentures 2014 GP LLC / MPM BioVentures 2014 LLC / EVNIN LUKE	S (D)	28,837	$7.13	3,885,115	Form 4
2026-09-09	MPM BioVentures 2018 GP LLC / MPM BioVentures 2018 LLC / MPM BIOVENTURES 2018, L.P.	S (D)	28,837	$7.13	3,885,115	Form 4
2026-09-08	MPM BIOVENTURES 2018 (B), L.P. / MPM Asset Management Investors BV2014 LLC / MPM BioVentures 2014 (B), L.P. / GADICKE ANSBERT / MPM BioVentures 2014, L.P. / MPM ASSET MANAGEMENT INVESTORS BV2018 LLC / Foley Todd / MPM BioVentures 2014 GP LLC / MPM BioVentures 2014 LLC / EVNIN LUKE	S (D)	192,500	$7.41	3,913,952	Form 4
2026-09-08	MPM BioVentures 2018 GP LLC / MPM BioVentures 2018 LLC / MPM BIOVENTURES 2018, L.P.	S (D)	192,500	$7.41	3,913,952	Form 4
2026-09-04	MPM BIOVENTURES 2018 (B), L.P. / MPM Asset Management Investors BV2014 LLC / MPM BioVentures 2014 (B), L.P. / GADICKE ANSBERT / MPM BioVentures 2014, L.P. / MPM ASSET MANAGEMENT INVESTORS BV2018 LLC / Foley Todd / MPM BioVentures 2014 GP LLC / MPM BioVentures 2014 LLC / EVNIN LUKE	S (D)	38,500	$7.11	4,106,452	Form 4
2026-09-04	MPM BioVentures 2018 GP LLC / MPM BioVentures 2018 LLC / MPM BIOVENTURES 2018, L.P.	S (D)	38,500	$7.11	4,106,452	Form 4
2026-09-03	MPM BioVentures 2014 GP LLC / EVNIN LUKE / MPM Asset Management Investors BV2014 LLC / MPM BioVentures 2014 (B), L.P. / MPM BioVentures 2014 LLC / GADICKE ANSBERT / Foley Todd / MPM BioVentures 2014, L.P. / MPM ASSET MANAGEMENT INVESTORS BV2018 LLC / MPM BIOVENTURES 2018 (B), L.P.	S (D)	32,263	$7.17	4,144,952	Form 4
2026-09-03	MPM BioVentures 2018 LLC / MPM BIOVENTURES 2018, L.P. / MPM BioVentures 2018 GP LLC	S (D)	32,263	$7.17	4,144,952	Form 4
2026-09-02	MPM BioVentures 2014 GP LLC / EVNIN LUKE / MPM Asset Management Investors BV2014 LLC / MPM BioVentures 2014 (B), L.P. / MPM BioVentures 2014 LLC / GADICKE ANSBERT / Foley Todd / MPM BioVentures 2014, L.P. / MPM ASSET MANAGEMENT INVESTORS BV2018 LLC / MPM BIOVENTURES 2018 (B), L.P.	S (D)	25,131	$7.19	4,177,215	Form 4
2026-09-02	MPM BioVentures 2018 LLC / MPM BIOVENTURES 2018, L.P. / MPM BioVentures 2018 GP LLC	S (D)	25,131	$7.19	4,177,215	Form 4
2026-09-02	Doshi Dipal	F (D)	8,724	$7.14	517,290	Form 4
2026-09-02	Wentworth Kory James	F (D)	1,733	$7.14	117,277	Form 4
2026-09-02	Dowden Nathan J	F (D)	2,528	$7.14	196,060	Form 4
2026-09-02	Sethuraman Natarajan	F (D)	2,079	$7.14	214,238	Form 4
2026-09-01	MPM BioVentures 2014 GP LLC / EVNIN LUKE / MPM Asset Management Investors BV2014 LLC / MPM BioVentures 2014 (B), L.P. / MPM BioVentures 2014 LLC / GADICKE ANSBERT / Foley Todd / MPM BioVentures 2014, L.P. / MPM ASSET MANAGEMENT INVESTORS BV2018 LLC / MPM BIOVENTURES 2018 (B), L.P.	S (D)	29,088	$7.06	4,202,346	Form 4
2026-09-01	MPM BioVentures 2018 LLC / MPM BIOVENTURES 2018, L.P. / MPM BioVentures 2018 GP LLC	S (D)	29,088	$7.06	4,202,346	Form 4
2026-08-31	MPM BioVentures 2014 (B), L.P. / Foley Todd / MPM BioVentures 2014 GP LLC / MPM ASSET MANAGEMENT INVESTORS BV2018 LLC / GADICKE ANSBERT / MPM Asset Management Investors BV2014 LLC / MPM BioVentures 2014 LLC / MPM BIOVENTURES 2018 (B), L.P. / EVNIN LUKE / MPM BioVentures 2014, L.P.	S (D)	44,259	$6.99	4,231,434	Form 4
2026-08-31	MPM BioVentures 2018 LLC / MPM BIOVENTURES 2018, L.P. / MPM BioVentures 2018 GP LLC	S (D)	44,259	$6.99	4,231,434	Form 4
2026-08-28	MPM BioVentures 2014 (B), L.P. / Foley Todd / MPM BioVentures 2014 GP LLC / MPM ASSET MANAGEMENT INVESTORS BV2018 LLC / GADICKE ANSBERT / MPM Asset Management Investors BV2014 LLC / MPM BioVentures 2014 LLC / MPM BIOVENTURES 2018 (B), L.P. / EVNIN LUKE / MPM BioVentures 2014, L.P.	S (D)	3,733	$7.01	4,275,693	Form 4
2026-08-28	MPM BioVentures 2018 LLC / MPM BIOVENTURES 2018, L.P. / MPM BioVentures 2018 GP LLC	S (D)	3,733	$7.01	4,275,693	Form 4
2026-08-27	MPM BioVentures 2014 (B), L.P. / Foley Todd / MPM BioVentures 2014 GP LLC / MPM ASSET MANAGEMENT INVESTORS BV2018 LLC / GADICKE ANSBERT / MPM Asset Management Investors BV2014 LLC / MPM BioVentures 2014 LLC / MPM BIOVENTURES 2018 (B), L.P. / EVNIN LUKE / MPM BioVentures 2014, L.P.	S (D)	38,922	$7.2	4,279,426	Form 4
2026-08-27	MPM BioVentures 2018 LLC / MPM BIOVENTURES 2018, L.P. / MPM BioVentures 2018 GP LLC	S (D)	38,922	$7.2	4,279,426	Form 4
2026-08-26	MPM BioVentures 2018 LLC / MPM BioVentures 2018 GP LLC / MPM BIOVENTURES 2018, L.P.	S (D)	14,569	$7.06	4,318,348	Form 4
2026-08-26	Foley Todd / MPM BioVentures 2014 GP LLC / MPM BioVentures 2014 LLC / MPM BioVentures 2014 (B), L.P. / MPM Asset Management Investors BV2014 LLC / GADICKE ANSBERT / MPM BIOVENTURES 2018 (B), L.P. / MPM BioVentures 2014, L.P. / EVNIN LUKE / MPM ASSET MANAGEMENT INVESTORS BV2018 LLC	S (D)	14,569	$7.06	4,318,348	Form 4
2026-08-25	MPM BioVentures 2018 LLC / MPM BioVentures 2018 GP LLC / MPM BIOVENTURES 2018, L.P.	S (D)	26,522	$7.54	4,332,917	Form 4
2026-08-25	Foley Todd / MPM BioVentures 2014 GP LLC / MPM BioVentures 2014 LLC / MPM BioVentures 2014 (B), L.P. / MPM Asset Management Investors BV2014 LLC / GADICKE ANSBERT / MPM BIOVENTURES 2018 (B), L.P. / MPM BioVentures 2014, L.P. / EVNIN LUKE / MPM ASSET MANAGEMENT INVESTORS BV2018 LLC	S (D)	26,522	$7.54	4,332,917	Form 4
2026-08-24	MPM BioVentures 2018 LLC / MPM BioVentures 2018 GP LLC / MPM BIOVENTURES 2018, L.P.	S (D)	21,623	$7.34	4,359,439	Form 4
2026-08-24	Foley Todd / MPM BioVentures 2014 GP LLC / MPM BioVentures 2014 LLC / MPM BioVentures 2014 (B), L.P. / MPM Asset Management Investors BV2014 LLC / GADICKE ANSBERT / MPM BIOVENTURES 2018 (B), L.P. / MPM BioVentures 2014, L.P. / EVNIN LUKE / MPM ASSET MANAGEMENT INVESTORS BV2018 LLC	S (D)	21,623	$7.34	4,359,439	Form 4
2026-08-10	Parmar Kush	S (D)	92,444	$7	2,691,337	Form 4
2026-08-07	ROCKLAGE SCOTT M / 5AM Opportunities I, L.P. / 5AM Partners V, LLC / 5AM Opportunities I (GP), LLC / 5AM Ventures V, L.P. / Schwab Andrew J.	S (D)	52,317	$6.85	2,783,781	Form 4
2026-08-07	Parmar Kush	S (D)	52,317	$6.85	2,783,781	Form 4
2026-08-06	ROCKLAGE SCOTT M / 5AM Opportunities I, L.P. / 5AM Partners V, LLC / 5AM Opportunities I (GP), LLC / 5AM Ventures V, L.P. / Schwab Andrew J.	S (D)	10,494	$7	2,836,098	Form 4
2026-08-06	Parmar Kush	S (D)	10,494	$7	2,836,098	Form 4
2026-07-31	ROCKLAGE SCOTT M / 5AM Ventures V, L.P. / Schwab Andrew J. / 5AM Partners V, LLC / 5AM Opportunities I (GP), LLC / 5AM Opportunities I, L.P.	S (D)	1,718	$6.85	2,846,592	Form 4
2026-07-31	Parmar Kush	S (D)	1,718	$6.85	2,846,592	Form 4
2026-07-30	ROCKLAGE SCOTT M / 5AM Ventures V, L.P. / Schwab Andrew J. / 5AM Partners V, LLC / 5AM Opportunities I (GP), LLC / 5AM Opportunities I, L.P.	S (D)	114,756	$6.93	2,848,310	Form 4
2026-07-30	Parmar Kush	S (D)	114,756	$6.93	2,848,310	Form 4

Transaction codes in this quarter

S: 33 F: 4

Get TRDA insider transactions through the API

Request with your API key

curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1689375&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · TRDA company page · Entrada Therapeutics, Inc. on SEC.gov

Questions

Are insiders buying or selling Entrada Therapeutics, Inc. (TRDA)?

In Q3 2026, insiders at Entrada Therapeutics, Inc. reported 37 non-derivative transactions on 16 Forms 3, 4 and 5: 0 open-market purchases and 33 sales worth $10.3M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Entrada Therapeutics, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/trda.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.